欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
SE/H/0918/003
药品名称
Numeta G19E
活性成分
glutamic acid 5.83 g
ornithine hydrochloride 1.85 g
tryptophan 1.17 g
tyrosine 0.45 g
threonine 2.16 g
taurine 0.35 g
soybean oil 0.0 g
sodium glycerophosphate 5.65 g
sodium chloride 4.57 g
serine 2.33 g
proline 1.75 g
potassium acetate 8.0 g
phenylalanine 2.45 g
olive oil 0.0 g
methionine 1.4 g
magnesium acetate 1.4 g
lysine monohydrate 7.2 g
leucine 5.83 g
isoleucine 3.9 g
histidine 2.21 g
glycine 2.33 g
glucose monohydrate 550.0 g
cysteine 1.1 g
calcium chloride 1.44 g
aspartic acid 3.5 g
arginine 4.89 g
alanine 4.66 g
valine 4.43 g
剂型
Emulsion for infusion
上市许可持有人
Baxter Medical AB Sweden
参考成员国 - 产品名称
Sweden (SE)
Numeta G19E
互认成员国 - 产品名称
Germany (DE)
NUMETA Ped G 19% E Emulsion zur Infusion
Denmark (DK)
Numeta Ped G19%E
Belgium (BE)
Numetzah G19%E émulsion pour perfusion
Netherlands (NL)
Luxembourg (LU)
United Kingdom (Northern Ireland) (XI)
Ireland (IE)
Austria (AT)
Numeta G 19 % E Emulsion zur Infusion
France (FR)
Spain (ES)
Portugal (PT)
Italy (IT)
Greece (GR)
Norway (NO)
Finland (FI)
许可日期
2010/12/15
最近更新日期
2024/01/16
药物ATC编码
B05BA10 combinations
申请类型
TypeLevel1:
Known Active Substance
TypeLevel2:
Additional Strength/Form
TypeLevel3:
Fixed combination Art 10b Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final PL
|
SE/H/0918/003_Final PL
Date of last change:2014/01/15
Final SPC
|
SE/H/0918/003_Final SPC
Date of last change:2014/01/15
PAR
|
SE/H/0918/003_PAR
Date of last change:2014/01/15
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase